Search Results - "Gooch, L"

Refine Results
  1. 1

    The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review by Szabo, Shelagh M, Salhany, Renna M, Deighton, Alison, Harwood, Meagan, Mah, Jean, Gooch, Katherine L

    Published in Orphanet journal of rare diseases (22-05-2021)
    “…Abstract Background Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited neuromuscular disorder, leading to loss of ambulation (LOA) and…”
    Get full text
    Journal Article
  2. 2

    Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia by Nabhan, Joseph F., Wood, Kristy M., Rao, Varada P., Morin, Jeffrey, Bhamidipaty, Surya, LaBranche, Timothy P., Gooch, Renea L., Bozal, Fazli, Bulawa, Christine E., Guild, Braydon C.

    Published in Scientific reports (17-02-2016)
    “…In Friedreich’s ataxia (FRDA) patients, diminished frataxin (FXN) in sensory neurons is thought to yield the predominant pathology associated with disease. In…”
    Get full text
    Journal Article
  3. 3

    Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity by Gooch, Jennifer L, King, Clayton, Francis, Cynthia E, Garcia, Paul S, Bai, Yun

    Published in PloS one (17-04-2017)
    “…Calcineurin inhibitors are powerful immunosuppressants that revolutionized organ transplantation. However, non-immune effects of the calcineurin inhibitor,…”
    Get full text
    Journal Article
  4. 4

    Motor unit number estimation: A technology and literature review by Gooch, Clifton L., Doherty, Timothy J., Chan, K. Ming, Bromberg, Mark B., Lewis, Richard A., Stashuk, Dan W., Berger, Michael J., Andary, Michael T., Daube, Jasper R.

    Published in Muscle & nerve (01-12-2014)
    “…ABSTRACT Introduction: Numerous methods for motor unit number estimation (MUNE) have been developed. The objective of this article is to summarize and compare…”
    Get full text
    Journal Article
  5. 5

    NADPH oxidase-2 mediates zinc deficiency-induced oxidative stress and kidney damage by Li, Mirandy S, Adesina, Sherry E, Ellis, Carla L, Gooch, Jennifer L, Hoover, Robert S, Williams, Clintoria R

    “…Zn deficiency (ZnD) is comorbid with chronic kidney disease and worsens kidney complications. Oxidative stress is implicated in the detrimental effects of ZnD…”
    Get more information
    Journal Article
  6. 6

    Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI) by Szabo, Shelagh M, Audhya, Ivana F, Rogula, Basia, Feeny, David, Gooch, Katherine L

    Published in Health and quality of life outcomes (11-06-2022)
    “…Data on health state utility in Duchenne muscular dystrophy (DMD) are few. This study estimated mean utility values by age, ambulatory status and over time,…”
    Get full text
    Journal Article
  7. 7

    Formoterol, a β2-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury by Vekaria, Hemendra J., Hubbard, W. Brad, Scholpa, Natalie E., Spry, Malinda L., Gooch, Jennifer L., Prince, Sydney J., Schnellmann, Rick G., Sullivan, Patrick G.

    Published in Neurobiology of disease (01-07-2020)
    “…Traumatic brain injury (TBI) leads to acute necrosis at the site of injury followed by a sequence of secondary events lasting from hours to weeks and often…”
    Get full text
    Journal Article
  8. 8

    Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis by Reilly, Margaret C., Gooch, Katherine L., Wong, Robert L., Kupper, Hartmut, van der Heijde, Désirée

    Published in Rheumatology (Oxford, England) (01-04-2010)
    “…Objective. To determine the validity, reliability and responsiveness of the Work Productivity and Activity Impairment questionnaire in AS (WPAI:SpA). Methods…”
    Get full text
    Journal Article
  9. 9

    The Association Between Overactive Bladder and Falls and Fractures: A Systematic Review by Szabo, Shelagh M., Gooch, Katherine L., Walker, David R., Johnston, Karissa M., Wagg, Adrian S.

    Published in Advances in therapy (01-11-2018)
    “…Introduction Urinary symptoms are associated with an increased risk of falls, but few studies have focused on patients with overactive bladder (OAB). This…”
    Get full text
    Journal Article
  10. 10

    Humoral factors in ALS patients during disease progression by Ehrhart, Jared, Smith, Adam J, Kuzmin-Nichols, Nicole, Zesiewicz, Theresa A, Jahan, Israt, Shytle, R Douglas, Kim, Seol-Hee, Sanberg, Cyndy D, Vu, Tuan H, Gooch, Clifton L, Sanberg, Paul R, Garbuzova-Davis, Svitlana

    Published in Journal of neuroinflammation (28-06-2015)
    “…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting upper and lower motor neurons in the CNS and leading to paralysis and death. There…”
    Get full text
    Journal Article
  11. 11

    Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases by Vonesh, E, Gooch, K L, Khangulov, V, Schermer, C R, Johnston, K M, Szabo, S M, Rumsfeld, J S

    Published in PloS one (16-10-2018)
    “…For managing overactive bladder (OAB), mirabegron, a β3 adrenergic receptor agonist, is typically used as second-line pharmacotherapy after antimuscarinics…”
    Get full text
    Journal Article
  12. 12

    Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks by Schwartz, Carolyn E, Stark, Roland B, Cella, David, Borowiec, Katrina, Gooch, Katherine L, Audhya, Ivana F

    Published in Orphanet journal of rare diseases (22-11-2021)
    “…Person-reported outcomes measurement development for rare diseases has lagged behind that of more common diseases. In studies of caregivers of patients with…”
    Get full text
    Journal Article
  13. 13

    Quantitative objective markers for upper and lower motor neuron dysfunction in ALS by MITSUMOTO, H, ULUG, A. M, MONTES, J, HAYES, S, DASHNAW, S, KAUFMANN, P, GORDON, P. H, HIRSCH, J, LEVIN, B, ROWLAND, L. P, SHUNGU, D. C, PULLMAN, S. L, GOOCH, C. L, CHAN, S, TANG, M.-X, MAO, X, HAYS, A. P, FLOYD, A. G, BATTISTA, V

    Published in Neurology (24-04-2007)
    “…To investigate the value of objective biomarkers for upper (UMN) and lower (LMN) motor neuron involvement in ALS. We prospectively studied 64 patients with ALS…”
    Get full text
    Journal Article
  14. 14

    Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec by Asher, Damon, Dai, Daisy, Klimchak, Alexa C., Sedita, Lauren E., Gooch, Katherine L., Rodino-Klapac, Louise

    “…Gene therapies have potential to improve outcomes of severe diseases after only a single administration. Novel therapies are continually being developed using…”
    Get full text
    Journal Article
  15. 15

    Dichloroacetate causes toxic neuropathy in MELAS : A randomized, controlled clinical trial by KAUFMANN, P, ENGELSTAD, K, PASCUAL, J. M, HIRANO, M, STACPOOLE, P. W, DIMAURO, S, DE VIVO, D. C, WEI, Y, JHUNG, S, SANO, M. C, SHUNGU, D. C, MILLAR, W. S, HONG, X, GOOCH, C. L, MAO, X

    Published in Neurology (14-02-2006)
    “…To evaluate the efficacy of dichloroacetate (DCA) in the treatment of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigation by Schwartz, Carolyn E., Stark, Roland B., Audhya, Ivana F., Gooch, Katherine L.

    Published in Journal of patient-reported outcomes (20-11-2021)
    “…Background This study examined the impact of Duchenne muscular dystrophy (DMD) on family-member caregivers in terms of quality of life, life stress, and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: A randomized, double-blinded trial by Ropper, Allan H., Gorson, Kenneth C., Gooch, Clifton L., Weinberg, David H., Pieczek, Ann, Ware, James H., Kershen, Joshua, Rogers, Adam, Simovic, Drasko, Schratzberger, Peter, Kirchmair, Rudolf, Losordo, Douglas

    Published in Annals of neurology (01-04-2009)
    “…Objective Randomized, blinded trial of intramuscular gene transfer using plasmid vascular endothelial growth factor (VEGF) to treat diabetic polyneuropathy…”
    Get full text
    Journal Article
  20. 20

    Impact of Age, Sex, Physical Function, Health-related Quality of Life, and Treatment with Adalimumab on Work Status and Work Productivity of Patients with Ankylosing Spondylitis by MAKSYMOWYCH, Walter P, GOOCH, Katherine L, WONG, Robert L, KUPPER, Hartmut, VAN DER HEIJDE, Désirée

    Published in Journal of rheumatology (01-02-2010)
    “…Objective. To determine factors associated with work in patients with ankylosing spondylitis (AS). Methods. Three hundred fifteen patients with AS were…”
    Get full text
    Journal Article